Genmab — Marts 2019
-
God morgen.
-
Roche, AbbVie forced to slam brakes on myeloma studies of star drug Venclexta after researchers flag higher risk of death https://endpts.com/roche-abbvie-slam-the-brakes-on-myeloma-studies-of-star-drug-venclexta-after-researchers-flag-higher-risk-of-death/
-
-
a bit surprised
they extend this Leukemia study with Ofatumumab? https://clinicaltrials.gov/ct2/history/NCT02199184?A=12&B=13&C=merged -
-
God eftermiddag. Hvis det virkeligt kun skal være lige så spændende at investere, som at se maling tørre, så må det snart være tid til et supplement i Genmab
-
Der er altid nogen som ved noget andre ikke ved..eller måske har vidst...eller tror de ved osv...:-D
-
Oppe 0,13% i dag. Det fejrer jeg med en påskebryg...skål..:-)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind